These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17083296)

  • 1. Inhibitory control in children with phenylketonuria.
    Christ SE; Steiner RD; Grange DK; Abrams RA; White DA
    Dev Neuropsychol; 2006; 30(3):845-64. PubMed ID: 17083296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria.
    White DA; Nortz MJ; Mandernach T; Huntington K; Steiner RD
    J Int Neuropsychol Soc; 2002 Jan; 8(1):1-11. PubMed ID: 11843066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive functioning, memory, and learning in phenylketonuria.
    Channon S; German E; Cassina C; Lee P
    Neuropsychology; 2004 Oct; 18(4):613-20. PubMed ID: 15506828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive response monitoring and inhibitory control in children with phenylketonuria: effects of expectancy.
    Araujo GC; Christ SE; Grange DK; Steiner RD; Coleman C; Timmerman E; White DA
    Dev Neuropsychol; 2013; 38(3):139-52. PubMed ID: 23573793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing speed and executive abilities in children with phenylketonuria.
    Janos AL; Grange DK; Steiner RD; White DA
    Neuropsychology; 2012 Nov; 26(6):735-43. PubMed ID: 22866986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of aging on executive and automatic inhibition.
    Andrés P; Guerrini C; Phillips LH; Perfect TJ
    Dev Neuropsychol; 2008; 33(2):101-23. PubMed ID: 18443972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive function profile of children with attention deficit hyperactivity disorder.
    Shallice T; Marzocchi GM; Coser S; Del Savio M; Meuter RF; Rumiati RI
    Dev Neuropsychol; 2002; 21(1):43-71. PubMed ID: 12058835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory control in children with autism spectrum disorder.
    Christ SE; Holt DD; White DA; Green L
    J Autism Dev Disord; 2007 Jul; 37(6):1155-65. PubMed ID: 17066307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoeducational findings among children treated for phenylketonuria.
    Fishler K; Azen CG; Henderson R; Friedman EG; Koch R
    Am J Ment Defic; 1987 Jul; 92(1):65-73. PubMed ID: 3618658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative priming effects in children engaged in nonspatial tasks: evidence for early development of an intact inhibitory mechanism.
    Pritchard VE; Neumann E
    Dev Psychol; 2004 Mar; 40(2):191-203. PubMed ID: 14979760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary management of phenylketonuria on long-term cognitive outcome.
    Channon S; Goodman G; Zlotowitz S; Mockler C; Lee PJ
    Arch Dis Child; 2007 Mar; 92(3):213-8. PubMed ID: 17068073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
    Sharman R; Sullivan K; Young R; McGill J
    Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological deficits in early treated phenylketonuric children.
    Pennington BF; van Doorninck WJ; McCabe LL; McCabe ER
    Am J Ment Defic; 1985 Mar; 89(5):467-74. PubMed ID: 3993693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
    Seashore MR; Friedman E; Novelly RA; Bapat V
    Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief report: manipulation of task difficulty in inhibitory control tasks.
    Lindqvist S; Thorell LB
    Child Neuropsychol; 2009 Jan; 15(1):1-7. PubMed ID: 18608218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive functions in individuals with Williams syndrome.
    Menghini D; Addona F; Costanzo F; Vicari S
    J Intellect Disabil Res; 2010 May; 54(5):418-32. PubMed ID: 20537048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.